Clinical Trials Directory

Trials / Completed

CompletedNCT01418547

Bioequivalence Study of Torrent Pharmaceutical Limited's Isosorbide Mononitrate 120 mg ER Tablets Under Fed Conditions

An Open Label, Randomized, Two Treatment, Two Sequence, Two Period, Cross-over, Single-dose Comparative Oral Bioavailability Study of Isosorbide Mononitrate 120 mg ER Tablets (Test) of Torrent Pharmaceuticals Ltd., India and Isosorbide Mononitrate 120 mg ER Tablets (Reference) of Kremers Urban, USA in Healthy, Adult, Male, Human Subjects Under Fed Conditions

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
Sponsor
Torrent Pharmaceuticals Limited · Industry
Sex
Male
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Objective: to compare the single dose bioavailability of Torrent's Isosorbide Mononitrate 120 mg ER Tablets (Test) and Isosorbide Mononitrate 120 mg ER Tablets (Reference) of Kremers Urban, USA under fed condition. Dosing periods were separated by a washout period of 8 days. Study Design: randomized, two-way crossover, single-dose, open-label study in healthy human adult subjects

Conditions

Interventions

TypeNameDescription
DRUGTorrent's Isosorbide Mononitrate 120 mg ER Tablets

Timeline

First posted
2011-08-17
Last updated
2011-08-17

Locations

2 sites across 1 country: India

Source: ClinicalTrials.gov record NCT01418547. Inclusion in this directory is not an endorsement.